- Home
- NGNE vs PCB Comparison
NGNE vs PCB Comparison
Compare NGNE & PCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGNE
- PCB
- Stock Information
- Founded
- NGNE 2003
- PCB 2003
- Country
- NGNE United States
- PCB United States
- Employees
- NGNE N/A
- PCB N/A
- Industry
- NGNE Biotechnology: Pharmaceutical Preparations
- PCB Major Banks
- Sector
- NGNE Health Care
- PCB Finance
- Exchange
- NGNE Nasdaq
- PCB Nasdaq
- Market Cap
- NGNE 325.3M
- PCB 289.7M
- IPO Year
- NGNE N/A
- PCB N/A
- Fundamental
- Price
- NGNE $18.48
- PCB $22.10
- Analyst Decision
- NGNE Strong Buy
- PCB Hold
- Analyst Count
- NGNE 7
- PCB 2
- Target Price
- NGNE $41.86
- PCB $22.25
- AVG Volume (30 Days)
- NGNE 110.1K
- PCB 26.5K
- Earning Date
- NGNE 08-11-2025
- PCB 10-23-2025
- Dividend Yield
- NGNE N/A
- PCB 3.62%
- EPS Growth
- NGNE N/A
- PCB 29.75
- EPS
- NGNE N/A
- PCB 2.14
- Revenue
- NGNE N/A
- PCB $102,259,000.00
- Revenue This Year
- NGNE N/A
- PCB $22.59
- Revenue Next Year
- NGNE N/A
- PCB $9.32
- P/E Ratio
- NGNE N/A
- PCB $10.33
- Revenue Growth
- NGNE N/A
- PCB 9.08
- 52 Week Low
- NGNE $6.88
- PCB $16.00
- 52 Week High
- NGNE $74.49
- PCB $22.45
- Technical
- Relative Strength Index (RSI)
- NGNE 35.93
- PCB 57.65
- Support Level
- NGNE $19.59
- PCB $21.97
- Resistance Level
- NGNE $20.46
- PCB $22.41
- Average True Range (ATR)
- NGNE 1.23
- PCB 0.38
- MACD
- NGNE -0.20
- PCB 0.05
- Stochastic Oscillator
- NGNE 13.37
- PCB 73.08
About NGNE Neurogene Inc.
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
About PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.